Colistin-glycopeptide combinations against multidrug-resistant in a mouse model of pneumonia.

To assess the effect of colistin-glycopeptide combination against a multidrug-resistant strain of .  We used procedures (Etest method, checkerboard test and kill-time assays) and a mouse model of a carbapenem-resistant pneumonia. The colistin-teicoplanin combination allowed a 74% increase of the survival in the mouse model within the 4 days following bacterial inoculation as compared with saline or colistin alone (p = 0.06). Concurrently, the colistin-vancomycin combination presented a similar efficacy as compared with saline or colistin alone in the mouse model. According to those preliminary results, using the colistin-teicoplanin combination in therapeutic deadlocks encountered in certain multiresistant pneumonia could be envisaged if the results are confirmed.